Statistical Learning as a Novel Intervention for Cortical Blindness

StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Enrolling by Invitation → Active, Not Recruiting
  2. Eligibility criteria expanded, about 27 words
  3. Primary completion date: Oct 1, 2026 to Oct 1, 2027v5
  4. Re-verified, no change to tracked fieldsv4
  5. Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Start date changed from estimate of Oct 1, 2024 to Nov 6, 2024
    v3
  6. Re-verified, no change to tracked fieldsv2
  7. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
University of Rochester
191 trials monitored
See 15 trials at risk
Stroke
3,544 trials monitored
See 167 trials at risk
This project aims to develop a novel visual training paradigm for use in visually-intact participants and those sufferings from stroke-induced visual impairments. Our task design is built upon theories of statistical learning to reduce the overall training burden while still producing profound improvements to visual abilities. Efficacy will be first established in visually-intact controls before testing in stroke survivors to assess the feasibility of this form of learning in the damaged visual system.
Trial Details
NCT Number NCT06578117
Lead Sponsor University of Rochester
Conditions
(from sponsor)		 Stroke, Ischemic, Hemianopia, Homonymous, Hemianopsia, Occipital Lobe Infarct, Visual Field Defect, Peripheral, Vision Loss Partial, Quadrantanopia, Stroke Hemorrhagic
Related terms Hemianopsia, Hemorrhagic Stroke, Ischemic Stroke
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov